Teva has announced a massive restructuring of its business, with 14,000 jobs to be cut, and R&D operations and regional headquarters to be closed around the world.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
